Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Clinical Pain 2020; 19(1): 8-15
Published online June 30, 2020 https://doi.org/10.35827/cp.2020.19.1.8
Copyright © Korean Association of Pain Medicine.
Byung Chan Lee, M.D.1, Ah Ran Kim, M.D.1, Eun Kyung Kim, M.S.2, Sun Jeong Kim, M.S.3 and Sang Jun Kim, M.D., Ph.D.4
이병찬1ㆍ김아란1ㆍ김은경2ㆍ김선정3ㆍ김상준4
Objective: To compare the therapeutic efficacy of the bone marrow aspirate concentrate (BMAC)- platelet-rich plasma (PRP) complex with hyaluronic acid in patients with knee osteoarthritis. Method: Thirty-four patients with knee osteoarthritis participated in this study. Seventeen patients in the study group underwent BMAC and PRP extraction followed by intra-articular injection of BMAC-PRP complex within affected knee. Seventeen patients in the control group underwent intra-articular injection of hyaluronic acid. Knee injury, osteoarthritic outcome score (KOOS), and EuroQol-5D (EQ-5D) questionnaire were evaluated before, one month, three months, and six months after the injection. Results: There were statistically significant temporal differences in total KOOS scores in both BMAC-PRP and HA groups. However, there were no significant group difference in the study period. In the Sports and Recreational Function Scale, there was statistically significant improvement in the BMAC-PRP group compared to the HA group at three months (p=0.041). There were no side effects or complications in both groups. Conclusion: Intra-articular injection of BMAC-PRP showed better functional recovery in the OA at three months and this can be an alternative treatment in terms of functional recovery in the OA in addition to the decrease of pain.
KeywordsBone marrow aspiration concentrates, Platelet rich plasma, Hyaluronic acid, Osteoarthritis, Knee